..until we get some sort of resolution one way or another. my understanding is 120 days from announcement of BTD is the deadline for new trial design to be submitted to FDA (although I suppose pandemic related lockdowns might count towards an extension).  I've seen school projects with stronger finances than RVX's right now. The way I see things there are only 2 ways forwards: i) they succeed in a fully funded partnership or ii) they fail to secure a partnership and have to raise more money, except I doubt anyone will have deep enough pockets to fund a go-it-alone strategy, which means I hope management's hand is forced to realise whatever value they can get to pass on stewardship to another company that will realise the full potential of this science.